只使用免费官方源:SEC Forms 3/4/5 结构化内部人申报,以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界,不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量;个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S(公开市场或私下交易),成交金额由股数 × 每股价格计算。
官方数据说明| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Kaplan Andrew T. Director,TenPercentOwner | 买入(P) | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCLS Fund IV Investments GP, LLC TenPercentOwner | 买入(P) | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCLS Fund IV Investments, L.P. TenPercentOwner | 买入(P) | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Life Sciences Fund IV, L.P. TenPercentOwner | 买入(P) | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Life Sciences IV General Partner, LLC TenPercentOwner | 买入(P) | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Life Sciences Investors, LLC TenPercentOwner | 买入(P) | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Koppel Adam Director,TenPercentOwner | 买入(P) | 1,562,500 | US$16.00 | US$2500万 | 22,583,268 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCPE Perseus Investor, LP TenPercentOwner | 买入(P) | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital Fund XIV, L.P. TenPercentOwner | 买入(P) | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | Bain Capital XIV General Partner, LLC TenPercentOwner | 买入(P) | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BCPE Perseus Investor GP, LLC TenPercentOwner | 买入(P) | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 2026-04-20 2026-04-20 | KLRA Kailera Therapeutics, Inc. | BAIN CAPITAL INVESTORS LLC TenPercentOwner | 买入(P) | 8,398,438 | US$16.00 | US$1.34亿 | 26,255,581 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| KLRA | 78,924.4036 | 0 | 151,025.5029 | 52.26% | B, Q, N |